This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4ob5
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10== | ==Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10== | ||
<StructureSection load='4ob5' size='340' side='right' caption='[[4ob5]], [[Resolution|resolution]] 1.70Å' scene=''> | <StructureSection load='4ob5' size='340' side='right' caption='[[4ob5]], [[Resolution|resolution]] 1.70Å' scene=''> | ||
| Line 4: | Line 5: | ||
<table><tr><td colspan='2'>[[4ob5]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OB5 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OB5 FirstGlance]. <br> | <table><tr><td colspan='2'>[[4ob5]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OB5 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OB5 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=TMO:TRIMETHYLAMINE+OXIDE'>TMO</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=TMO:TRIMETHYLAMINE+OXIDE'>TMO</scene></td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ob5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ob5 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ob5 RCSB], [http://www.ebi.ac.uk/pdbsum/4ob5 PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ob5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ob5 OCA], [http://pdbe.org/4ob5 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4ob5 RCSB], [http://www.ebi.ac.uk/pdbsum/4ob5 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4ob5 ProSAT]</span></td></tr> |
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| Line 14: | Line 15: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4ob5" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 15:43, 11 August 2016
Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10
| |||||||||||
